In the March issue Dr. Leeb highlights three stocks that are the masters of moats and are run by leaders with astute long-term thinking.Two of the stocks are already stalwarts of our Growth Portfolio, and the third one we are watching very closely and may add to our portfolio soon. He also spotlights a health-foods retailer that had fallen on hard times in recent years. He will monitor the company's comeback closely.
In the Growth Portfolio section, Dr. Leeb reviews our biotech holdings, including a long-time recommendation that recently had a spinoff. He decides to sell one. In the Income Portfolio, we highlight an MLP that recently was bought out by its general partner. In other sections we also look at two gold miner companies, headed in different directions lately. Read the issue for more! Read more about Masters of Moats
The market is close to a tipping point. As I said last week, barring some major event, out of the blue, such as an attack on the Middle East oil infrastructure, I do not expect a huge correction. For market participants, given the slow but very steady increase in stocks, a setback of even 5 percent will come as a semi-shock. Read more about Market Close to Tipping Point 02-27-17
In the 1980s, long before the euro was even an abstract dream, much less a gleam in the eye of globalist planners, key European nations had an economic union of sorts, among them West Germany, France, Italy, and several more. Italy then found itself in perpetual economic straits. Read more about Situation Critical, But Not Serious 02-21-17